| Refining stability and dissolution rate of amorphous drug formulations H Grohganz, PA Priemel, K Löbmann, LH Nielsen, R Laitinen, A Mullertz, ... Expert opinion on drug delivery 11 (6), 977-989, 2014 | 143 | 2014 |
| Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous mats for wound healing YM Liu X, Nielsen LH, Klodzinska SN, Nielsen HM, Qu H, Christensen LP ... European Journal of Pharmaceutics and Biopharmaceutics, 2017 | 129* | 2017 |
| Development of electrosprayed mucoadhesive chitosan microparticles JAS Moreno, AC Mendes, K Stephansen, C Engwer, FM Goycoolea, ... Carbohydrate polymers 190, 240-247, 2018 | 85 | 2018 |
| Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats LH Nielsen, S Gordon, R Holm, A Selen, T Rades, A Müllertz European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 942-951, 2013 | 83 | 2013 |
| From concept to in vivo testing: Microcontainers for oral drug delivery. BA Mazzoni C, Tentor F, Andersen SS, Nielsen LH, Keller SS, Alstrøm TS ... Journal of Controlled Release 268, 343-351, 2017 | 81 | 2017 |
| Polymeric microcontainers improve oral bioavailability of furosemide LH Nielsen, A Melero, SS Keller, J Jacobsen, T Garrigues, T Rades, ... International journal of pharmaceutics 504 (1-2), 98-109, 2016 | 80 | 2016 |
| Spatial confinement can lead to increased stability of amorphous indomethacin LH Nielsen, SS Keller, KC Gordon, A Boisen, T Rades, A Müllertz European journal of pharmaceutics and biopharmaceutics 81 (2), 418-425, 2012 | 76 | 2012 |
| Microfabricated devices for oral drug delivery LH Nielsen, SS Keller, A Boisen Lab on a Chip 18 (16), 2348-2358, 2018 | 74 | 2018 |
| Polymeric nano-and microparticulate drug delivery systems for treatment of biofilms SE Birk, A Boisen, LH Nielsen Advanced Drug Delivery Reviews 174, 30-52, 2021 | 73 | 2021 |
| Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin A Nielsen, L.H., Rades, T., Boyd, B., Boisen European Journal of Pharmaceutics and Biopharmaceutics 118, 13-20, 2017 | 50 | 2017 |
| Nanomechanical Infrared Spectroscopy with Vibrating Filters for Pharmaceutical Analysis A Kurek, M, Carnoy, M., Larsen, P.E., Nielsen, L.H., Hansen, O., Rades, T ... Angewandte Chemie - International Edition 56, 3901-3905, 2017 | 41* | 2017 |
| pH-triggered drug release from biodegradable microwells for oral drug delivery LH Nielsen, J Nagstrup, S Gordon, SS Keller, J Østergaard, T Rades, ... Biomedical microdevices 17, 1-7, 2015 | 41 | 2015 |
| Animal models for evaluation of oral delivery of biopharmaceuticals NHM Harloff-Helleberg S, Nielsen LH Journal of Controlled Release, 2017 | 39 | 2017 |
| Stability, liposome interaction, and in vivo pharmacology of ghrelin in liposomal suspensions EH Moeller, B Holst, LH Nielsen, PS Pedersen, J Østergaard International journal of pharmaceutics 390 (1), 13-18, 2010 | 38 | 2010 |
| Mental sundhed og sygdom hos børn og unge i alderen 10-24 år P Jeppesen, C Obel, L Lund, KB Madsen, L Nielsen, M Nordentoft Vidensråd for Forebyggelse, 2020 | 36 | 2020 |
| Microcontainers for protection of oral vaccines, in vitro and in vivo evaluation C von Halling Laier, B Gibson, JAS Moreno, T Rades, S Hook, LH Nielsen, ... Journal of controlled release 294, 91-101, 2019 | 36 | 2019 |
| Spray dried cubosomes with ovalbumin and Quil-A as a nanoparticulate dry powder vaccine formulation C von Halling Laier, B Gibson, M van de Weert, BJ Boyd, T Rades, ... International Journal of Pharmaceutics 550 (1-2), 35-44, 2018 | 36 | 2018 |
| Microcontainers for oral insulin delivery–in vitro studies of permeation enhancement JR Jørgensen, ML Jepsen, LH Nielsen, M Dufva, HM Nielsen, T Rades, ... European Journal of Pharmaceutics and Biopharmaceutics 143, 98-105, 2019 | 35 | 2019 |
| Drug loaded biodegradable polymer microneedles fabricated by hot embossing TE Andersen, AJ Andersen, RS Petersen, LH Nielsen, SS Keller Microelectronic Engineering 195, 57-61, 2018 | 34 | 2018 |
| Biorelevant characterisation of amorphous furosemide salt exhibits conversion to a furosemide hydrate during dissolution LH Nielsen, S Gordon, JP Pajander, J Østergaard, T Rades, A Müllertz International journal of pharmaceutics 457 (1), 14-24, 2013 | 34 | 2013 |
